Ellen Lavoie Smith, PhD, University of Michigan School of Nursing, and her team have published results of a phase 3 study showing that patients receiving duloxetine had a reduction in pain symptoms over a 5 week period. And, more patients initially treated with duloxetine, had even greater incidence of pain reduction. READ MORE from MedPage Today …
A controlled clinical study from Boston University School of Medicine and the Veterans Administration indicates that cognitive behavioral therapy (CBT) can help relieve chronic pain for people suffering with type II diabetes. Left untreated, elevated glucose levels can develop into nerve damage, causing painful burning and stinging sensations in the hands and feet. DPN patients …
Behavioral Therapy Eases Pain from Diabetic Neuropathy Read More »
A new drug therapy, nabilone, has been tested at University of Calgary’s Hotchkiss Brain Institute. At the end of the study, patients reported less pain and an improvement in sleep and anxiety when taking nabilone. The drug is currently used in Canada to treat nausea in chemotherapy patients. Nabilone is a synthetic cannabinoid, which mimics some …
Drug Offers New Pain Management Therapy for Diabetics Read More »
According to research at the University of Maryland School of Medicine, Baltimore, acupuncture relieves cancer pain due to medication side effects. Testing was done on patients using bortezomib for multiple myeloma. READ MORE Source: HealthCMI
Janssen Pharmaceuticals, Inc. announced the FDA has approved the supplemental New Drug Application for NUCYNTA ER extended-release tables for the management of neuropathic pain associated with diabetic peripheral neuropathy. NUCYNTA ER is the first and only opioid approved by the FDA for this purpose. “Pain from DPN can be difficult to manage, leaving some patients …
FDA Approves NUCYNTA ER Extended Release Oral Tablets Read More »
Two clinical trials, one in the US and one in China have been completed on the results of taking Acetyl-l-Carnitine, either during chemotherapy treatments or before treatment. With very different results presented at the American Society of Clinical Oncology annual meeting, there is no clear direction on the use of ALC. Debra Barton, PhD, Mayo Clinic, commented, “Further …
Acetyl-l-Carnitine Yield Mixed Results for Chemo-Induced Neuropathy Read More »
First published online by BioMed Central, researchers from Tehran and Tabriz Universities, Iran, have found that Omega-3 fatty acids have beneficial effects on neurological disorders from the side effects of paclitaxel, used to treat breast cancer. Omega-3 fatty acids may be an efficient neuroprotective agent against paclitaxel-induced PN. READ MORE Source: Equities.com
New study has been published showing the potential of stem cells providing relief to people suffering from painful diabetic peripheral neuropathy (DPN). Stem Cells Translational Medicine published the study on July 9th. Inflammation is considered a major culprit in DPN. While there are treatments for the diabetes and to helping to alleviate pain, Dr. Ruth …
New Type of Stem Cell Preparation Could Bring Pain Relief to Diabetics Read More »
Duloxetine, known commercially as Cymbalta, has been shown to relieve neuropathic pain caused by chemotherapy in 59 percent of patients in a recent study at the University of Michigan. Lead study author, Ellen M. Lavoie Smith, PhD, and researcher at the U-M Comprehensive Cancer Center, says, “These drugs don’t work for everyone. The good news …
Antidepressant Helps Relieve Pain from Chemotherapy Read More »
Scientists at the University of CA San Francisco have published new findings in Neuron regarding the use of stem cells to treat chronic nerve pain. Led by Dr. Allan Basbaum, the teams believes stem cells may possibly cure some types of neuropathic conditions. READ MORE from EmaxHelath or READ MORE from Neuron. Source: EmaxHealth; Neuron
